Brick & Kyle, Associates - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 161 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
Brick & Kyle, Associates ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$51,000
+75.9%
1,3000.0%0.04%
+73.9%
Q4 2016$29,000
+45.0%
1,300
+44.4%
0.02%
+43.8%
Q3 2016$20,000
-39.4%
900
-35.7%
0.02%
-40.7%
Q2 2016$33,000
+13.8%
1,4000.0%0.03%
+8.0%
Q1 2016$29,000
-59.7%
1,4000.0%0.02%
-60.3%
Q4 2015$72,000
+89.5%
1,400
+55.6%
0.06%
+75.0%
Q3 2015$38,000
-53.7%
900
-50.0%
0.04%
-47.8%
Q2 2015$82,000
+20.6%
1,8000.0%0.07%
+19.0%
Q1 2015$68,000
+51.1%
1,800
+12.5%
0.06%
+48.7%
Q4 2014$45,0001,6000.04%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 232,952$5,498,0005.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,673,727$86,700,0003.41%
Redmile Group, LLC 1,466,537$34,610,0003.31%
SECTORAL ASSET MANAGEMENT INC 1,229,382$29,013,0003.00%
HARVEY CAPITAL MANAGEMENT INC 206,530$4,874,0002.44%
Marcus Capital, LLC 75,150$1,774,0001.87%
Cormorant Asset Management, LP 396,000$9,346,0001.32%
Rail-Splitter Capital Management, LLC 221,414$5,225,0001.25%
Temasek Holdings (Private) Ltd 6,583,568$155,372,0001.21%
EMERALD MUTUAL FUND ADVISERS TRUST 636,526$15,022,0000.84%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders